Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...

Two healthcare stocks that may or may not be boring, but that regardless look like strong growth stocks to invest in this ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Big pharma’s pushing for PBS funding, and it’s kickstarting a shift to healthier snacks, smaller portions, and more ...

Sitting at a market capitalization of $159 billion, Amgen (AMGN) is a biotech powerhouse. Founded in 1980, it is one of the biggest names in the healthcare and biotech industry, with a strong history ...

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

The stock's fall snapped a four-day winning streak.

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price ...

This page features the latest news about the Eli Lilly DRC stock. Eli Lilly stock soars to all-time high of $967 amid robust growth Eli Lilly and Co's stock has reached an unprecedented peak ...

ByReuters • Nov 22, 2024 China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug (Reuters) - Eli Lilly (NYSE:LLY) and Hong Kong-listed Laekna will collaborate to ...